NATURAL PRODUCT RESEARCH AND DEVELOPMENT ›› 2025, Vol. 37 ›› Issue (5): 816-827. doi: 10.16333/j.1001-6880.2025.5.003 cstr: 32307.14.1001-6880.2025.5.003

Previous Articles     Next Articles

Analysis of blood-absorbed components of Alocasiae Cucullatae Rhizoma aqueous extract based on UPLC-QE Orbitrap MS/MS

LUO Hui-min, ZHU Hua *, XU Li-ba, WANG Bing-bing, LI Mei-lin, LU Lu, ZHANG Miao*, CHEN Long   

  1. Guangxi Key Laboratory of Zhuang and Yao Ethnic Medicine, Engineering Research Center for Development and Industrialization of Zhuang and Yao Medicinal Materials, Collaborative Innovation Center of Zhuang and Yao Ethnic Medicine, Guangxi Zhuang Autonomous Region Ethnic Medicine Resources and Application Research Center of Engineering, Guangxi University of Chinese Medicine, Nanning 530200, China
  • Online:2025-05-28 Published:2025-05-26

Abstract:

This study utilized ultra-high-performance liquid chromatography coupled with quadrupole-electrostatic field orbitrap high-resolution tandem mass spectrometry (UPLC-QE Orbitrap MS/MS) to identify the chemical components in Alocasiae Cucullatae Rhizoma aqueous extract (ACRAE) and rat serum. Chromatographic separation was performed using a gradient elution with a mobile phase of water (containing 0.1% formic acid) and acetonitrile at a flow rate of 0.35 mL/min, with an injection volume of 5 μL. Mass spectrometric analysis was carried out with a heated electrospray ionization (HESI) source, and data were acquired in both positive and negative ion modes over a scanning range of m/z 100–1 200. By comparing the chromatographic profiles of ACRAE, blank serum, and drug-containing serum, prototype components and metabolites in the serum after oral administration were identified based on retention times, molecular weights, and both primary and secondary ion fragments. A total of 135 chemical components were characterized in the ACRAE. In serum, 68 blood-absorbed components were detected, including 23 prototype components and 45 metabolites. The rapid profiling of blood-absorbed components in ACRAE via UPLC-QE Orbitrap MS/MS provides critical insights for further exploration of its pharmacodynamic material basis and mechanisms of action.

Key words: Alocasiae Cucullatae Rhizoma, UPLC-QE Orbitrap MS/MS, blood-absorbed components, prototype components, metabolites

CLC Number: